Back to UBS Group AG UBS Group AG

BIAFBIAF
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in BIOAFFINITY TECHNOLOGIES INC

UBS Group AG holds 4,204 shares of BIAF (BIOAFFINITY TECHNOLOGIES INC), worth $3,414 as of 2026-Q2. The position was decreased (-54.4% shares).

Current Value

$3,414

Current Shares

4,204

Total Value Change

+$2,991

Total Shares Change

+4,061

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
4,204
-54.4%
$3,4140.0%$0.81
0
2026-Q1
New
9,214
-
$35,2900.0%$0.95
30
2025-Q4
Exited
0
-100.0%
$00.0%$1.23
0
2025-Q3
New
143
-
$4230.0%$3.25
17

Other major holders of BIAF: VANGUARD CAPITAL MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD FIDUCIARY TRUST CO, Schonfeld Strategic Advisors LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used